141 results
Page 5 of 8
8-K
om6hnktxyu7a8kps6no8
19 Jun 20
Patent License Agreement
5:26pm
8-K
20iu11bgayzo pyfy1
15 Jun 20
Entry into a Material Definitive Agreement
4:13pm
8-K
0l8vlhi pwt
29 May 20
Vir Biotechnology and Biogen Execute Agreement to ManufactureSARS-CoV-2 Antibodies for PotentialCOVID-19 Treatment
4:06pm
8-K
EX-99.1
5mkcxark8opi
29 May 20
Vir Biotechnology and Biogen Execute Agreement to ManufactureSARS-CoV-2 Antibodies for PotentialCOVID-19 Treatment
4:06pm
8-K
EX-99.1
t1sfhd1p
12 May 20
Vir Biotechnology Provides Corporate Update and Reports First Quarter 2020 Financial Results
4:05pm
8-K
cjtod3jagr19pnnehxi1
10 Apr 20
Samsung Biologics and Vir Biotechnology Enter into Agreement for Large Scale Manufacture ofSARS-COV-2 Antibodies for Potential COVID-19 Treatment
8:01am
8-K
EX-99.1
oots00z7
10 Apr 20
Samsung Biologics and Vir Biotechnology Enter into Agreement for Large Scale Manufacture ofSARS-COV-2 Antibodies for Potential COVID-19 Treatment
8:01am
DEF 14A
09s0sci1tzvkyzyx0
6 Apr 20
Definitive proxy
4:52pm
8-K
EX-99.1
xkxyq0ng
6 Apr 20
Entry into a Material Definitive Agreement
8:02am
8-K
xzmhmay8lk5 9g5f8s
6 Apr 20
Entry into a Material Definitive Agreement
8:02am
10-K
9vo5hybef4h8bbw
26 Mar 20
Annual report
4:08pm
10-K
EX-4.4
4ts6tr rtpkzc
26 Mar 20
Annual report
4:08pm
10-K
EX-10.12
nn6m1 ln94
26 Mar 20
Annual report
4:08pm
8-K
EX-99.1
cde7ohjd
26 Mar 20
Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2019 Financial Results
4:01pm
10-Q
743622bxne
19 Nov 19
Quarterly report
4:06pm
S-8
EX-4.11
3mviav7 o8z3vct0yh
15 Oct 19
Registration of securities for employees
4:47pm
S-8
EX-4.8
tjdasqrz64h83e
15 Oct 19
Registration of securities for employees
4:47pm
424B4
src0 mvcef
11 Oct 19
Prospectus supplement with pricing info
5:31pm
S-1/A
EX-1.1
89v00j41d8nwut5l
30 Sep 19
IPO registration (amended)
6:12am